Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Lucyd, Inc

Lucyd, Inc (LUCY) Stock Overview

Explore Lucyd, Inc’s financial performance, market position, analyst ratings, and future outlook.

LUCY●NASDAQ
HealthcareMedical - Instruments & Supplies
$0.65
$0.04(6.40%)
U.S. Market opens in 14h 25m

Lucyd, Inc (LUCY)

Meyka AI Score

Z

Key Financials

Market Cap2.6M
P/E Ratio-0.38
EPS (TTM)$-1.69
ROE-0.83%
Fundamental Analysis

AI Price Forecasts

1 Month$0.45
3 Months$2.38
1 Year Target$0.00

LUCY Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Lucyd, Inc (NASDAQ: LUCY) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Lucyd, Inc's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LUCY on the NASDAQ shows an RSI of 34.20, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Lucyd, Inc's NASDAQ-traded stock include a P/E ratio of -0.38 and a market capitalization of 2.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of LUCY on the NASDAQ.

Price Performance (NASDAQ: LUCY)

1-Day Change
-6.40%
5-Day Change
-21.68%
1-Month Change
-14.93%
3-Month Change
-38.02%
6-Month Change
-53.18%
Year-to-Date (YTD) Change
-34.69%
1-Year Change
-68.86%
3-Year Change
-96.07%
5-Year Change
-99.45%
All-Time (Max) Change
-99.45%

Contact Information

https://lucyd.co
786-785-5178
11900 Biscayne Blvd., North Miami, FL, 33181

Company Facts

130 Employees
IPO DateAug 15, 2022
CountryUS
Actively Trading

Frequently Asked Questions